newsfilter
← Latest News
PR Newswire·

BioSpecifics Technologies Corp. Names J. Kevin Buchi as Chief Executive Officer

BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company that originated and continues to develop collagenase-based therapies with ...